As of June 10, 2025, BioCorRx Inc (BICX) reports a ROE (Return on Equity) of 42.13%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of BioCorRx Inc's ROE (Return on Equity)
Over recent years, BioCorRx Inc's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | 42.13% |
| 2023-12-31 | 38.35% |
| 2022-12-31 | 54.08% |
| 2021-12-31 | 76.17% |
| 2020-12-31 | 84.84% |
This slight downward trend highlights how BioCorRx Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing BioCorRx Inc's ROE (Return on Equity) to Peers
To better understand BioCorRx Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| BioCorRx Inc (BICX) | 42.13% |
| Tocca Life Holdings Inc (TLIF) | 538.85% |
| Capital Senior Living Corp (CSU) | 105.76% |
| Tenet Healthcare Corp (THC) | 76.72% |
| Extendicare Inc (EXE.TO) | 60.48% |
| Medical Facilities Corp (DR.TO) | 60.23% |
Compared to its competitors, BioCorRx Inc's ROE (Return on Equity) is among the highest compared to peers, suggesting efficient use of shareholder equity to generate profits.